期刊文献+

p-STAT3蛋白在增生性瘢痕中的表达及意义 被引量:1

Expression of STAT3 protein in hypertrophic scar and its significance
原文传递
导出
摘要 目的检测JAK2/STAT3信号通路中STAT3蛋白在人增生性瘢痕中的表达,探讨其在增生性瘢痕中的作用及意义。方法采用免疫组织化学方法和Western blot检测方法分别检测32例增生性瘢痕和22例正常皮肤组织中p-STAT3的表达情况。结果(1)免疫组织化学检测显示,p-STAT3蛋白在增生性瘢痕及正常皮肤组织中均有表达,染色阳性物质主要位于细胞质,少部分位于细胞核,在表皮和真皮层均有表达,在增生性瘢痕组织中表达量均高于正常皮肤组织,差异具有统计学意义(P=0);(2)Western blot检测结果显示,增生性瘢痕中p-STAT3蛋白的表达均较正常皮肤高,差异具有统计学意义(P<0.05)。结论增生性瘢痕中p-STAT3呈现高表达,提示JAK2/STAT3信号通路异常激活可能在增生性瘢痕发生过程中起重要作用。 Objective To investigate the expression of STAT3 protein of JAK2/STAT3 pathway in hypertrophic scars and its significance.Methods The expression of p-STAT3 in 32 cases of hypertrophic scar and 22 cases of normal skin were detected by immunohistochemistry (IHC) and Western blot.Results (1) IHC showed that p-STAT3 protein was expressed in both hypertrophic scar and normal skin.Normal skin tissue staining substances are mainly located in the cytoplasm,with a small part in the nucleus.The level of p-STAT3 protein in hypertrophic scars was higher than that in the normal skin,the difference had a statistical significance (P =0);(2) Western blot showed that the expression of p-STAT3 in the hypertrophic sear fibroblasts was higher than that in the normal human skins;the difference had a statistical significance (P < 0.05).Conclusion The strong expressions of p-STAT3 in hypertrophic scars indicated that the abnormal activity of the JAK2/STAT3 pathway may play an important role in the occurrence of the hypertrophic scar.
出处 《中国美容整形外科杂志》 CAS 2016年第6期375-377,共3页 Chinese Journal of Aesthetic and Plastic Surgery
关键词 增生性瘢痕 JAK2/STAT3信号通路 P-STAT3 Hypertrophic scar JAK2/STAT3 pathway p-STAT3
  • 相关文献

参考文献15

  • 1Mair M, Blaas L, Osterreicher CH, et al. JAK-STAT signaling in he-parle fibrosis[J]. Front Biosci(Landmark Ed), 2011 ,(16) :2794-2811.
  • 2Vera J, Rateitschak K, Lange F, et al. Systems biology of JAK- STAT signaling in human malignancies[J]. Prog Biophys Mol Bi- ol, 2011,106(2) :426-434.
  • 3Matsui F, Meldrum KK. The role of the Janus kinase family/signal transducer and activator of transcription signaling pathway in fibrot- ic renal disease[ J ]. J Surg Res, 2012,178 (1) :339-345.
  • 4罗佳,章敬成,刘繁荣,吴冬梅,廖首生,杨宇晴.肝癌组织中FMNL-2和MMP-2的表达及临床病理分析[J].肿瘤防治研究,2014,41(5):460-463. 被引量:6
  • 5贾赤宇.增生性瘢痕防治研究进展与挑战[J].中华烧伤杂志,2012,28(5):393-395. 被引量:4
  • 6尹文洁,梁月琴.增生性瘢痕形成过程中的多因素研究现状及展望[J].中华医学美学美容杂志,2014,20(1):77-80. 被引量:10
  • 7Jatiani SS, Baker SJ, Silverman LR, et al. JAK/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies [ J ]. Genes Cancer, 2010,1 ( 10 ) :979-993.
  • 8Numasaki M, Watanabe M, Suzuki T, et al. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis[ J]. J Immunol, 2005,175 (9) :617745189.
  • 9Pang M, Kothapally J, Mao H, et al. Inhibition of histone deacety- lase activity attenuates renal fibroblast activation and interstitial fi- brosis in obstructive nephropathy[J]. Am J Physiol Renal Physiol, 2009,297(4) : 1;996-F1005.
  • 10Martfnez-Caselles A, Pons-Minano JA, Vargas-Acosta A, et al. Hepatoportal sclerosis clinical different evolutionary stages: pres- entation of 3 cases and literature review [ J ]. Rev Esp Enferm Dig, 2012,104(2) :94-97.

二级参考文献79

  • 1Grieb G, Steffens G, Pallua N, et al. Circulating fibrocytes-bi-ology and mechanisms in wound healing and scar formation. Int Rev Cell Mol Biol, 2011,291:1-19.
  • 2Ali SS, Hajrah NH, Ayuob NN, et al. Morphological and mor- phometric study of cultured fibroblast from treated and untreated abnormal scar. Saudi Med J, 2010,31 (8) :874-881.
  • 3Abdou AG, Maraee AH, A1-Bara AM, et al. Immunohistochemi- cal expression of TGF-β1 in keloids and hypertrophic scars. Am J Dermatopathol, 2011,33(1 ) :84-91.
  • 4Gauglitz GG, Korting HC, Pavicic T, et al. Hypertrophic scar- ring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med, 2011,17(1/2) :113-125.
  • 5Berman B. Biological agents for controlling excessive scarring. Am J Clin Dermatol, 2010,11 Suppl 1:31-34.
  • 6van der Veer WM, Ferreira JA, de Jong EH, et al. Perioperative conditions affect long-term hypertrophic scar formation. Ann Plast Surg, 2010,65 (3) :321-325.
  • 7Yang JY, Huang CY. The effect of combined steroid and calcium channel blocker injection on human hypertrophic scars in animal model: a new strategy for the treatment of hypertrophic scars. Dermatol Surg, 2010,36(12) :1942-1949.
  • 8Yates CC, Krishna P, Whaley D, et al. Lack of CXC chemokine receptor 3 signaling leads to hypertrophic and hypercellular scar- ring. Am J Pathol, 2010,176(4):1743-1755.
  • 9Shetlar MR, Shetlar CL, Hendricks L, et al. The use of athymic nude mice for the study of human keloids. Proc Soc Exp Biol Med, 1985,179(4) :549-552.
  • 10Wei Y J, Yan XQ, Ma L, et al. Oleanolic acid inhibits hyper- trophic scarring in the rabbit ear model. Clin Exp Dermatol, 2011,36(5) :528-533.

共引文献31

同被引文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部